MICHAEL WILMORE: Open Payments
NPI 1396806402 · WASHINGTON, DC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$508 in 18 payments from 6 companies in 2025. Trend: 2023 $146 · 2024 $537 · 2025 $508
Food & beverage: $508
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 11 | $179 |
| Novo Nordisk Inc | 3 | $159 |
| ABBVIE INC. | 1 | $113 |
| Theratechnologies Inc. | 1 | $23 |
| Merck Sharp & Dohme LLC | 1 | $18 |
| Currax Pharmaceuticals LLC | 1 | $16 |
Products named: Wegovy, BOTOX, EGRIFTA, PIFELTRO, CONTRAVE.
Industry payments across DC — which companies pay providers there.
